ES525138A0 - Un procedimiento para la preparacion de derivados de azetidina. - Google Patents

Un procedimiento para la preparacion de derivados de azetidina.

Info

Publication number
ES525138A0
ES525138A0 ES525138A ES525138A ES525138A0 ES 525138 A0 ES525138 A0 ES 525138A0 ES 525138 A ES525138 A ES 525138A ES 525138 A ES525138 A ES 525138A ES 525138 A0 ES525138 A0 ES 525138A0
Authority
ES
Spain
Prior art keywords
procedure
preparation
azetidine derivatives
azetidine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES525138A
Other languages
English (en)
Other versions
ES8502708A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP57145574A external-priority patent/JPS5946265A/ja
Priority claimed from JP57158604A external-priority patent/JPS5951286A/ja
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of ES525138A0 publication Critical patent/ES525138A0/es
Publication of ES8502708A1 publication Critical patent/ES8502708A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • C07D477/04—Preparation by forming the ring or condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568—Four-membered rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES525138A 1982-08-24 1983-08-24 Un procedimiento para la preparacion de derivados de azetidina. Expired ES8502708A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP57145574A JPS5946265A (ja) 1982-08-24 1982-08-24 アゼチジノン誘導体の製造法
JP57158604A JPS5951286A (ja) 1982-09-10 1982-09-10 カルバペネム誘導体の製造法

Publications (2)

Publication Number Publication Date
ES525138A0 true ES525138A0 (es) 1985-01-16
ES8502708A1 ES8502708A1 (es) 1985-01-16

Family

ID=26476650

Family Applications (3)

Application Number Title Priority Date Filing Date
ES525138A Expired ES8502708A1 (es) 1982-08-24 1983-08-24 Un procedimiento para la preparacion de derivados de azetidina.
ES531561A Expired ES8602796A1 (es) 1982-08-24 1984-04-12 Un procedimiento para la preparacion de derivados de azetidina
ES531562A Expired ES8507491A1 (es) 1982-08-24 1984-04-12 Un procedimiento para la preparacion de derivados de azetidina

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES531561A Expired ES8602796A1 (es) 1982-08-24 1984-04-12 Un procedimiento para la preparacion de derivados de azetidina
ES531562A Expired ES8507491A1 (es) 1982-08-24 1984-04-12 Un procedimiento para la preparacion de derivados de azetidina

Country Status (7)

Country Link
US (1) US5856556A (es)
EP (1) EP0102239B1 (es)
KR (1) KR900006449B1 (es)
CA (1) CA1232903A (es)
DE (1) DE3374063D1 (es)
ES (3) ES8502708A1 (es)
FI (1) FI80887C (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4696923A (en) * 1984-04-23 1987-09-29 Merck & Co., Inc. 6-[1-hydroxyethyl]-2-SR8 -1-methyl-1-carbadethiapen-2-em-3-carboxylic acids
DK270685A (da) * 1984-06-29 1985-12-30 Hoffmann La Roche Carbapenemderivater
US4895939A (en) * 1986-02-24 1990-01-23 Bristol-Myers Company High percentage β-yield synthesis of carbapenem intermediates
KR880006244A (ko) * 1986-11-24 1988-07-22 후지사와 도모 기찌 로 3-피롤리디닐티오-1-아자바이스클로[3.2.0]햅트2-엔-2-카르복실산 화합물 및 이의 제조방법
DE3784147T2 (de) * 1986-11-24 1993-06-03 Fujisawa Pharmaceutical Co 3-pyrrolidinylthio-1-azabicyclo(3.2.0)hept-2-en-2-carbonsaeure-derivate.
US4820815A (en) * 1987-09-01 1989-04-11 University Of Notre Dame Du Lac Azetidinone N-phosphonomethyl esters
US4925838A (en) * 1988-03-18 1990-05-15 Fujisawa Pharmaceutical Company, Ltd. 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
GB8811237D0 (en) * 1988-05-12 1988-06-15 Fujisawa Pharmaceutical Co 3-pyrrolidinylthio-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid derivatives
US4963544A (en) * 1988-05-23 1990-10-16 Fujisawa Pharmaceutical Company, Ltd. 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
GB8923844D0 (en) * 1989-10-23 1989-12-13 Fujisawa Pharmaceutical Co Carbapenem compounds
IL99513A0 (en) * 1990-09-20 1992-08-18 Hoechst Ag Process for the preparation of carbapenem compounds
GB9103034D0 (en) * 1991-02-13 1991-03-27 Fujisawa Pharmaceutical Co Processes for preparing carbapenem derivatives
GB9305813D0 (en) * 1993-03-20 1993-05-05 Glaxo Spa Chemical process
US6395894B2 (en) 1998-04-16 2002-05-28 Philip J. Pye Process for the synthesis of carbapenem intermidiates, and compounds produced
US6489471B1 (en) 1998-06-17 2002-12-03 Merck & Co., Inc. Process for the synthesis of carbapenem intermediates, and compounds produced
US6194568B1 (en) 1998-07-13 2001-02-27 Merck & Co., Inc. Process for synthesizing carbapenem intermediates
US7241308B2 (en) * 2003-06-09 2007-07-10 Xtent, Inc. Stent deployment systems and methods
GB0400382D0 (en) * 2004-01-09 2004-02-11 Glaxo Group Ltd Novel processes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593524A (en) * 1976-11-19 1981-07-15 Merck & Co Inc 1-carba-2-penem-3-carboxylic acids
US4348320A (en) * 1976-11-19 1982-09-07 Merck & Co., Inc. Substituted azetidiones
US4446146A (en) * 1978-07-26 1984-05-01 Beecham Group Limited β-Lactam containing compounds, their preparation and use
JPS579784A (en) * 1980-06-23 1982-01-19 Sankyo Co Ltd Production of penem-3-carboxylic derivative
DK329381A (da) * 1980-07-24 1982-01-25 Takeda Chemical Industries Ltd Fremgangsmaade til frmstilling af 1,1-disubstitueret carba-z -penem samt salte og estere deraf
US4347183A (en) * 1981-02-02 1982-08-31 Schering Corporation Process for the synthesis of penems and carbapenems
EP0057565A1 (en) * 1981-02-04 1982-08-11 Beecham Group Plc Beta-lactam antibiotics, their preparation and use
ZA821361B (en) * 1981-03-04 1983-01-26 Beecham Group Plc Beta-lactam antibiotics,their preparation and use

Also Published As

Publication number Publication date
FI80887B (fi) 1990-04-30
US5856556A (en) 1999-01-05
ES531561A0 (es) 1985-12-01
DE3374063D1 (en) 1987-11-19
FI80887C (fi) 1990-08-10
ES531562A0 (es) 1985-09-01
KR900006449B1 (ko) 1990-08-31
EP0102239A1 (en) 1984-03-07
ES8502708A1 (es) 1985-01-16
KR840006008A (ko) 1984-11-21
CA1232903A (en) 1988-02-16
ES8602796A1 (es) 1985-12-01
EP0102239B1 (en) 1987-10-14
ES8507491A1 (es) 1985-09-01
FI833034A0 (fi) 1983-08-24
FI833034A7 (fi) 1984-02-25

Similar Documents

Publication Publication Date Title
ES521121A0 (es) Un procedimiento para la preparacion de derivados de benzotia-zolsulfonamida.
ES528627A0 (es) Un procedimiento para la preparacion de pirazolo-y piridazo-pirazolinas,-piridazinas y-diazepinas.
ES539625A0 (es) Un procedimiento para la preparacion de derivados de fenetano.
ES521635A0 (es) Un procedimiento para la preparacion de nuevos derivados de fosfolipidos.
ES520132A0 (es) Un procedimiento para la preparacion de derivados de 1-normon-2-ilo.
ES520730A0 (es) Un procedimiento para la prepracion de nuevas benzolactamas.
ES524446A0 (es) Un procedimiento para la preparacion de nuevos derivados.
ES536525A0 (es) Un procedimiento para la preparacion de derivados de fenotiazinas.
ES535953A0 (es) Un procedimiento para la preparacion de derivados 3-cefem-4-carboxilicos.
ES524447A0 (es) Un procedimiento para la preparacion de nuevos derivados arilfenolicos.
ES522678A0 (es) Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina.
ES530418A0 (es) Un procedimiento para la preparacion de pirazolopiridinas.
ES538907A0 (es) Un procedimiento para la preparacion de derivados enol-eteres de oxicanis.
ES531562A0 (es) Un procedimiento para la preparacion de derivados de azetidina
ES521318A0 (es) Un procedimiento para la preparacion de compuestos de bencimidazol.
ES529846A0 (es) Un procedimiento para la preparacion de derivados benzoheterociclicos.
ES524610A0 (es) Un procedimiento para la preparacion de nuevos derivados de fosfolipidos.
ES522120A0 (es) Un procedimiento para la preparacion de 4-aril-4-piperidincarbinoles.
ES524317A0 (es) Un procedimiento para la preparacion de nuevos derivados de tienopirimidina.
ES528079A0 (es) Un procedimiento para la preparacion de nuevos derivados de carbapenem.
ES521277A0 (es) Un procedimiento para la preparacion de derivados de penem sustituidos.
ES521192A0 (es) Un procedimiento para la preparacion de derivados de b-lactama.
ES529213A0 (es) Un procedimiento para la preparacion de derivados de isoquinuclidina.
ES522389A0 (es) Un procedimiento para la preparacion de nuevos derivados de penem-2-tiosustituidos.
ES526528A0 (es) Un procedimiento para la preparacion de derivados de difenilalquilenicos.